comparemela.com

Latest Breaking News On - Nareg minaskeian - Page 1 : comparemela.com

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options

United statesSimos kedikoglouNareg minaskeianVishu raoOussama wazniJaved butlerUniversity of mississippiCardiovascular associates in mesaBaylor scott white research instituteBaylor scott white health systemImpulse dynamicsHeart failureRejection fractionMedical directorSouthwest cardiovascular associatesBaylor scott

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer Study

Implantable device trial to treat heart failure in higher ER population; Trial evaluates FDA-designated breakthrough therapy for patients who lack treatment options.

United statesSimos kedikoglouNareg minaskeianVishu raoOussama wazniJaved butlerHeart failure groupUniversity of mississippiCardiovascular associates in mesaBaylor scott white research instituteBaylor scott white health systemImpulse dynamicsHigher ejection fractionMedical directorSouthwest cardiovascular associatesBaylor scott

Impulse Dynamics Announces First Patient Enrolled in AIM

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options.

United statesSimos kedikoglouNareg minaskeianVishu raoOussama wazniJaved butlerHeart failure groupCardiovascular associates in mesaBaylor scott white health systemUniversity of mississippiBaylor scott white research instituteHigher ejection fractionImpulse dynamicsMedical directorSouthwest cardiovascular associatesBaylor scott

vimarsana © 2020. All Rights Reserved.